Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
3 hedge funds and large institutions have $53K invested in Bionano Genomics, Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
59% less capital invested
Capital invested by funds: $129K → $53K (-$76K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$17.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.77K |
BNGOW Hedge Fund Activity: Q1 2022 in Review
3 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q1 2022, worth a combined $53K — down 59% from $129K a quarter earlier.
Fund positioning in BNGOW was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Privium Fund Management, cutting an estimated $17.8K.
- 3 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $53K of Bionano Genomics, Inc. Warrant stock for Q1 2022, down 59% quarter-over-quarter.
- 0 funds opened new Bionano Genomics, Inc. Warrant positions in Q1 2022 and 0 closed out.
- The largest Bionano Genomics, Inc. Warrant seller in Q1 2022 was Privium Fund Management, an estimated $17.8K sold.
Based on aggregated 13F filings for Q1 2022.